Avinash Ravi For and on behalf of Dr. R.T. Ravi Mrs. Hemalata Ravi Mr. Avinash Ravi Mr. Aditya Ravi Mr. Ajay Ravi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The promoters of Krebs Biochemicals and Industries Limited have submitted a declaration to the exchanges confirming that they have not created any encumbrance (pledge) on their shares during the financial year ended 31st March, 2026. The declaration covers all five promoters including Dr. R.T. Ravi, Mrs. Hemalata Ravi, Mr. Avinash Ravi, Mr. Aditya Ravi, and Mr. Ajay Ravi along with persons acting in concert. This is a regulatory compliance filing under SEBI takeover regulations requiring disclosure of share encumbrances by promoters.
Positive signal for shareholders as it confirms promoters have not pledged their shares, which maintains their commitment and reduces risk of forced selling. No immediate impact on stock price expected from this filing.